Sigma-Aldrich

Sigma-Aldrich, VIB ink alliance on novel translational research tools

Friday, January 23, 2015 11:46 AM

Sigma-Aldrich's research business unit, which supports translational researchers by supplying the products, services and solutions needed to enable scientific discovery, has formed an alliance with VIB, a life science research institute based in Flanders, Belgium, focused on translational research in medical, agricultural and industrial applications. The alliance will focus on the commercialization and supply of new tools and technologies to help meet the evolving needs of translational researchers.

More... »

Quest Diagnostics

Merck, Pfizer ink alliance on anti-PD-L1

Monday, November 17, 2014 02:28 PM

Merck has entered into a global agreement with Pfizer to co-develop and co-commercialize MSB0010718C, an investigational anti-PD-L1 antibody currently in development by Merck as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.

More... »


Horizon Discovery Group acquires Sage Labs for $48M

Wednesday, October 1, 2014 01:18 PM

Horizon Discovery Group, a Cambridge, U.K.-based international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, has agreed to acquire Sage Labs, a St. Louis, Mo.-based provider of advanced in vivo transgenic disease models for use in preclinical research, for up to $16 million in cash and up to $32 million through the issue of new ordinary shares.

More... »

Merck to acquire Sigma-Aldrich

Monday, September 22, 2014 02:31 PM

Merck has agreed to acquire Sigma-Aldrich, a St. Louis, Mo.-based life science and technology company, for $17 billion in an all-cash transaction.

More... »

Sigma-Aldrich, University of Michigan Medical School partner

Friday, September 19, 2014 12:45 PM

Sigma-Aldrich (SIAL), a St. Louis, Mo.-based life science and high technology company, has entered into a new gene editing partnership with the University of Michigan (U-M) Medical School's Vector Core. Sigma-Aldrich will provide the Vector Core with Sigma CRISPR technology, experimental design consultation and dedicated gene editing bioinformaticians.

More... »

SAFC to support next-gen NSAID product development

Monday, November 5, 2012 11:16 AM

Sigma-Aldrich’s custom manufacturing and services business unit, SAFC, has signed an agreement with South Korea-based CrystalGenomics, a clinical stage biopharmaceutical company, to support the development of active pharmaceutical ingredients (APIs) for next-generation non-steroidal anti-inflammatory drugs (NSAID).

More... »

Sigma-Aldrich acquires Research Organics

Wednesday, April 4, 2012 10:53 AM

Sigma-Aldrich, a life science and high technology company, has acquired all outstanding shares of Cleveland-based Research Organics, a supplier of high purity biochemicals.

More... »


CWWeekly

May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs